Last week, the Chief Secretary to the Treasury, Cabinet Minister Rt Hon Danny Alexander MP, visited BIA member company ReNeuron. As a senior member of the UK government it was great to see his interest in ensuring the fiscal environment for bioscience remains positive, and that he was interested in learning more about the regulatory and reimbursement challenges in developing innovative medicines and therapeutics for areas of unmet medical need.
I was pleased to see that the Mayor of London announced funding to establish Med City in London. The Mayor and his team see Med City as part of a global hub for medical innovation and discovery that will draw in investment, established pharmaceutical companies and start-ups. I am looking forward to working with the Mayor, Deputy Mayor Kit Malthouse and his team to ensure that this initiative works to deliver healthcare benefits to patients and to boost the UK economy.
Following on from our recent CEO and Investor Forum we have added posts highlighting some of the key sessions to our blog: a summary of my conversation with Patrick Verheyen, head of Johnson & Johnson’s (J&J) innovation centre in London; an overview of discussions on sector financing; and David Hipkiss, CEO of Prosonix’s tips for things he wished he had known when he started out as a CEO.
Looking forward to the second half of this year, the BIA will be delivering over 30 events and mission for the sector. BIA will be working in partnership with Biopartner and UKTI to lead lifescience trade missions to Brazil, Australia, China, Europe and the USA. Often there is financial assistance available to eligible participants. Find out more on our website.
On a personal note can I thank members for their kind wishes on the birth of my son Teddy last week, both he and my wife Jess are doing well – although we are a little short of sleep this summer in the Bates household.